Medical Equipment

Global Diabetes Treatment Devices Market Report 2026–2035: Key Forecasts and Growth Areas

February 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

How is the Diabetes Treatment Devices Market size predicted to change over the forecast window of 2026–2035?

The market for diabetes treatment devices has shown substantial growth in recent years. It is anticipated to expand from $12.34 billion in 2025 to $13.11 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.2%. This historical growth was influenced by factors such as the prevalence of traditional blood glucose meters, restricted awareness of self-monitoring devices, the expansion of hospital and diagnostic center infrastructure, the rising prevalence of diabetes, and the adoption of standard lancets and testing strips.

The diabetes treatment devices market is projected to experience robust expansion over the next few years. It is expected to reach $16.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This projected growth can be attributed to the development of smart insulin pens and pumps, increasing adoption of real-time continuous glucose monitoring, integration with smartphones and wearable devices, expanding remote patient monitoring programs, and the growth of diabetes clinics and online distribution channels. Prominent trends anticipated during this period include the growing uptake of continuous glucose monitoring devices, a rising preference for smart insulin delivery systems, an increase in homecare and remote patient monitoring, the expansion of wearable and handheld glucometers, and a heightened demand for safety-enhanced lancets and testing strips.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

Which Drivers Are Contributing To The Expansion Of The Diabetes Treatment Devices Market?

The future growth of the diabetes treatment devices market is anticipated to be propelled by increasing obesity rates. An obesity rate refers to the proportion of individuals classified as obese based on their body mass index (BMI). These rising obesity rates are primarily attributed to unhealthy diets high in calories, sugars, and fats, which lead to excessive weight gain when not balanced with physical activity. Diabetes treatment devices contribute to reducing obesity rates by fostering better blood sugar control, thereby supporting healthier lifestyle habits and weight management. For instance, in September 2024, the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, reported that in 2023, adult obesity rates reached 35% or higher in 23 US states, an increase from 22 states in 2022, signaling a worsening obesity trend. Thus, increasing obesity rates are driving the growth of the diabetes treatment devices market.

What Segment Categories Are Covered In The Diabetes Treatment Devices Market?

The diabetes treatment devices market covered in this report is segmented –

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

5) By Lancets: Standard Lancets, Safety Lancets

6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

8) By Transmitters: Reusable Transmitters, Disposable Transmitters

9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

What Trends Are Reshaping The Dynamics Of The Diabetes Treatment Devices Market?

Leading companies in the diabetes treatment devices market are emphasizing the integration of sophisticated automation technologies, such as automated insulin delivery algorithms, to improve treatment precision and achieve continuous glycemic control. These algorithms utilize real-time glucose data from continuous glucose monitoring sensors to autonomously adjust basal insulin dosing, aiding in the maintenance of glucose levels within the target range with minimal manual oversight. For example, in April 2023, Medtronic plc, a US-based medical technology company, obtained FDA approval for the MiniMed 780G System, an automated insulin delivery technology crafted to assist individuals with type 1 diabetes by automatically rectifying high glucose levels and adjusting insulin delivery every five minutes. The system is equipped with SmartGuard technology for insulin adjustments that respond to real-time glucose, features bluetooth connectivity for mobile monitoring, and provides integrated continuous glucose monitoring support. The MiniMed 780G System enhances treatment accuracy, glucose stability, and daily diabetes management outcomes.

Which Key Players Are Driving Competition In The Diabetes Treatment Devices Market?

Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

How Does The Diabetes Treatment Devices Market Perform Across Major Global Regions?

North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Diabetes Treatment Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2026, By The Business Research Company

Pet Diabetes Care Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

Insulin Delivery Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Continuous Glucose Monitoring Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795